DAE HWA Pharmaceutical Co. Ltd (067080) — Tangible Net Worth Ratio
DAE HWA Pharmaceutical Co. Ltd (067080) has a Tangible Net Worth Ratio of 65.2% as of March 2026. This metric is calculated by deducting intangible assets (₩29.56 Billion) from net assets (₩85.06 Billion) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Also explore DAE HWA Pharmaceutical Co. Ltd (067080) equity growth momentum to track the company's year-over-year net asset growth rate.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
DAE HWA Pharmaceutical Co. Ltd Tangible Net Worth Ratio (2011–2025)
This chart shows how DAE HWA Pharmaceutical Co. Ltd's Tangible Net Worth Ratio has changed across 15 annual periods from 2011 to 2025. As of March 2026, the ratio stands at 65.2%, reflecting net assets of ₩85.06 Billion with intangible assets of ₩29.56 Billion KRW. For live market cap and overall valuation, see DAE HWA Pharmaceutical Co. Ltd market capitalisation.
Annual Tangible Net Worth Ratio for DAE HWA Pharmaceutical Co. Ltd (2011–2025)
The table below presents the year-by-year Tangible Net Worth Ratio for DAE HWA Pharmaceutical Co. Ltd from 2011 to 2025, covering 15 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. Explore DAE HWA Pharmaceutical Co. Ltd (067080) reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
| Year | Tangible NW Ratio | Net Assets (KRW) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 62.6% | ₩79.14 Billion | ₩29.61 Billion | ₩210.86 Billion | ▲ +2.4 pp |
| 2024 | 60.2% | ₩72.00 Billion | ₩28.63 Billion | ₩205.88 Billion | ▼ -1.8 pp |
| 2023 | 62.0% | ₩73.23 Billion | ₩27.82 Billion | ₩219.16 Billion | ▼ -3.4 pp |
| 2022 | 65.4% | ₩77.99 Billion | ₩26.97 Billion | ₩199.06 Billion | ▼ -4.7 pp |
| 2021 | 70.2% | ₩79.67 Billion | ₩23.77 Billion | ₩177.38 Billion | ▼ -5.7 pp |
| 2020 | 75.9% | ₩81.98 Billion | ₩19.76 Billion | ₩175.05 Billion | ▼ -6.1 pp |
| 2019 | 82.0% | ₩79.35 Billion | ₩14.32 Billion | ₩166.15 Billion | ▼ -0.7 pp |
| 2018 | 82.7% | ₩76.88 Billion | ₩13.33 Billion | ₩162.06 Billion | ▼ -4.2 pp |
| 2017 | 86.9% | ₩76.75 Billion | ₩10.08 Billion | ₩165.47 Billion | ▼ -4.5 pp |
| 2016 | 91.4% | ₩66.15 Billion | ₩5.68 Billion | ₩153.80 Billion | ▲ +0.2 pp |
| 2015 | 91.2% | ₩61.06 Billion | ₩5.35 Billion | ₩124.61 Billion | ▲ +3.1 pp |
| 2014 | 88.2% | ₩58.51 Billion | ₩6.93 Billion | ₩124.07 Billion | ▼ -3.3 pp |
| 2013 | 91.5% | ₩62.03 Billion | ₩5.27 Billion | ₩121.87 Billion | ▼ -4.7 pp |
| 2012 | 96.2% | ₩61.39 Billion | ₩2.35 Billion | ₩130.19 Billion | ▼ -0.4 pp |
| 2011 | 96.6% | ₩56.99 Billion | ₩1.94 Billion | ₩135.58 Billion | — |